tm
Seeing Is Believing
tm
Seeing Is Believing
Currently out of the existing stock ratings of Bill Maughan, 11 are a BUY (64.71%), 6 are a HOLD (35.29%).
Analyst Bill Maughan, currently employed at CANACCORD, carries an average stock price target met ratio of 36.11% that have a potential upside of 65.48% achieved within 161 days.
Bill Maughan’s has documented 33 price targets and ratings displayed on 6 stocks. The coverage is on the Healthcare sector.
Most recent stock forecast was given on FATE, Fate Therapeutics at 10-May-2024.
Analyst best performing recommendations are on IMCR (IMMUNOCORE HOLDINGS LTD).
The best stock recommendation documented was for IMCR (IMMUNOCORE HOLDINGS LTD) at 2/29/2024. The price target of $63 was fulfilled within 8 days with a profit of $4.22 (6.28%) receiving and performance score of 7.85.
Average potential price target upside
Analyst name
Rating
Current price target
Potential Upside
Previous price target
Date
Price targets met ratio
Average potential upside
Average Time (Days) For PT To Be Met
Performance score
Buy
$24
$11 (84.62%)
$22
4 days ago
(07-Mar-2025)
0/12 (0%)
$11 (84.62%)
Buy
$20
$7 (53.85%)
$20
7 months 5 days ago
(06-Aug-2024)
1/3 (33.33%)
$12.09 (152.84%)
36
Buy
$21
$8 (61.54%)
$18
1 years 6 months 4 days ago
(07-Sep-2023)
1/5 (20%)
$16.4 (356.52%)
788
Buy
$13
$25
1 years 6 months 23 days ago
(16-Aug-2023)
2/4 (50%)
$7.59 (140.30%)
382
Buy
$14
$-2.28 (-14.00%)
$17
2 years 3 months 18 days ago
(21-Nov-2022)
1/2 (50%)
$11.06 (376.19%)
788
What Year was the first public recommendation made by Bill Maughan?
